The role of endorectal coil MRI in patient selection and treatment planning for prostate seed implants

International Journal of Radiation Oncology Biology Physics

Volumn 52, Issue 4, 2002, Pages 903-910

  Clarke, Daniel H ^a   Banks, Stephen J ^a   Wiederhorn, A Roger ^b   Klousia, John W ^c   Lissy, Jeanne M ^a   Miller, Michelle ^a   Able, Arnold M ^a   Artiles, Carlos ^d   Hindle, William V ^d   Blair, Deborah N ^d   Houk, Russell R ^d   Sheridan, Michael J ^e  

^a Inova Alexandria Cancer Center   (United States)

^b Sports Medicine   (United States)

^c Adult and Pediatric Urologists of Northern Virginia   (United States)

^d INOVA ALEXANDRIA HOSPITAL   (United States)

^e INOVA Health Care System   (United States)

Author keywords

Endorectal coil MRI; Palladium 103; Prostate brachytherapy; Prostate seed implants

Indexed keywords

BIOPSY; DISEASES; MAGNETIC RESONANCE IMAGING; OPTIMIZATION; RADIOTHERAPY; REGRESSION ANALYSIS; SEED; TUMORS;

SEED IMPLANTATION (SI);

ONCOLOGY;

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BEAM THERAPY; BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ENDORECTAL COIL MAGNETIC RESONANCE IMAGING; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; TREATMENT OUTCOME; TREATMENT PLANNING;

BRACHYTHERAPY; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PALLADIUM; PATIENT SELECTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOISOTOPES; REGRESSION ANALYSIS;

EID: 18344393445     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)02736-5     Document Type: Article

References (18)

1. Interstitial implantation techniques in prostate cancer
2. Prostate specific antigen-monitored combination radiotherapy for patients with prostate cancer
3. Defining the implant treatment volume for patients with low risk prostate cancer: Does the anterior base need to be treated?
4. Brachytherapy and organ preservation in the management of carcinoma of the prostate
5. Planned extracapsular seed placement using Palladium-103 for prostate brachytherapy
6. Prostate brachytherapy: Improvements in prostate volume measurements and dose distribution using interactive ultrasound guided implantation and three-dimensional dosimetry
7. Brachytherapy boost techniques for locally advanced prostate cancer
8. A survey of physics and dosimetry practice of permanent prostate brachytherapy in the United States
9. Comparability of CT-based and TRUS-based prostate volumes
10. Dosimetry guidelines to minimize urethral and rectal morbility following transperineal I-125 prostate brachytherapy
11. A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancer
12. Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer
13. The role of MR imaging in the selection of therapy for prostate cancer
14. Prostate cancer: Effect of postbiopsy hemorrhage on interpretation of MR images
15. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer
16. Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate
17. Calculated prostate cancer volume: The optimal predictor of actual cancer volume and pathologic stage
18. Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer